BRIEF published on 08/01/2025 at 14:05, 10 months 1 day ago CARMAT: Resumption of Quotation and Update on Judicial Recovery Takeover Offer CARMAT Resumption Of Quotation Judicial Recovery Aeson® Artificial Heart
BRIEF published on 07/01/2025 at 20:50, 11 months 1 day ago Half-yearly report on CARMAT's liquidity contract Liquidity Contract Actions CARMAT Judicial Recovery Stockbroker
BRIEF published on 06/20/2025 at 19:15, 11 months 12 days ago CARMAT launches a donation campaign in the face of a financial crisis Funding Heart Failure Artificial Heart Financial Crisis Donation Campaign
PRESS RELEASE published on 06/20/2025 at 19:10, 11 months 12 days ago Inside Information / Other news releases CARMAT launches a donation campaign to address critical financial situation and risk of insolvency. The initiative aims to secure urgent funding for its innovative total artificial heart Financial Situation CARMAT Artificial Heart Donation Campaign Risk Of Insolvency
BRIEF published on 06/04/2025 at 17:50, 11 months 28 days ago CARMAT: Terms and conditions for the General Meeting of June 26, 2025 General Assembly Remote Voting CARMAT Artificial Heart Financial Risks
BRIEF published on 06/02/2025 at 07:05, 1 year ago CARMAT makes its first sales of artificial hearts in Israel CARMAT European Union Israel Aeson® Locations
BRIEF published on 04/09/2025 at 17:50, 1 year 1 month ago CARMAT Achieves Strong Q1 2025 Results CARMAT Q1 2025 FDA Discussions Aeson® Implants EFICAS Trial
PRESS RELEASE published on 04/09/2025 at 17:45, 1 year 1 month ago Inside Information / Other news releases CARMAT delivers strong Q1 2025 results with €2.4m sales, progresses EFICAS trial, and advances FDA discussions for EFS study in the US. Aiming for long-term patient support with enhanced heart by end of 2025 CARMAT Long-term Support FDA Discussions Q1 2025 Results EFICAS Trial
BRIEF published on 02/17/2025 at 07:05, 1 year 3 months ago CARMAT's Aeson® Artificial Heart: Promising Results for Heart Failure with Pulmonary Hypertension Medical Innovation Heart Failure Treatment Aeson® Artificial Heart Pulmonary Hypertension Transplant Eligibility
PRESS RELEASE published on 02/17/2025 at 07:00, 1 year 3 months ago Inside Information / Other news releases CARMAT's Aeson® total artificial heart, featured in The Journal of Heart and Lung Transplantation, offers a promising solution for heart failure patients with pulmonary hypertension, potentially becoming a standard treatment Heart Failure CARMAT Aeson® Pulmonary Hypertension Transplant
Published on 06/03/2026 at 09:01, 30 minutes ago Apex Announces Drill Program Expansion and H2 Exploration Plans at the Rift Rare Earth Project
Published on 06/03/2026 at 04:58, 4 hours 33 minutes ago Snipp Interactive Reports Q1 2026 Financial Results; Bookings Backlog Reaches Record $20.6 Million; Announces Conference Call on Wednesday, June 3, 2026
Published on 06/03/2026 at 00:00, 9 hours 31 minutes ago Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program
Published on 06/02/2026 at 22:30, 11 hours 1 minute ago INEO Announces Effective Date of Share Consolidation
Published on 06/03/2026 at 09:27, 3 minutes ago Bajaj Mobility AG for its 100% subsidiary KTM AG: Senior Executive to strengthen R&D - Christof Lischka appointed Chief Technology and Product Officer of KTM AG
Published on 06/03/2026 at 09:18, 13 minutes ago Homann Holzwerkstoffe publishes its 2025 Sustainability Statement and is already using the revised ESRS
Published on 06/03/2026 at 09:05, 26 minutes ago Dstny Launches Always-On Communications: Business Communications That Never Sleep
Published on 06/03/2026 at 09:00, 31 minutes ago Original-Research: LION E-Mobility AG (von NuWays AG): BUY
Published on 06/03/2026 at 08:45, 46 minutes ago Air Liquide announces milestone investment in South Korea to support SK hynix’s advanced AI memory chip project
Published on 06/02/2026 at 18:03, 15 hours 28 minutes ago Total number of voting rights and shares making up the share capital at May 31, 2026
Published on 06/02/2026 at 17:42, 15 hours 49 minutes ago Aéroports de Paris SA - Shares and voting rights as of 31 May 2026
Published on 06/02/2026 at 17:40, 15 hours 51 minutes ago Campus AI enters the implementation phase: Eiffage selected for deployment of shared infrastructure on the Fouju Campus in a deal worth over €120 million
Published on 06/02/2026 at 08:00, 1 day 1 hour ago EURAZEO’S PRIVATE DEBT FUND CLOSES AT RECORD €3.9 BILLION, EXCEEDING ITS INITIAL TARGET
